Copertina

Confidence Intervals for Adaptive Trial Designs II : Case Study and Practical Guidance

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	David S. Robertson, Thomas Burnett, Babak Choodari‐Oskooei, Munya Dimairo, Michael Grayling, Philip Pallmann, Thomas Jaki
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Statistics in Medicine
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Confidence intervals for adaptive trial designs II: Case study and practical guidance
di: Robertson, David S., et al.
Pubblicazione: (2024)

Confidence intervals for adaptive trial designs I: A methodological review
di: Robertson, David S., et al.
Pubblicazione: (2024)

Clinical Trial Simulation: Planning With the OCTAVE Framework, Implementation and Validation Principles
di: Kim May Lee, et al.
Pubblicazione: (2026)

Adding experimental treatment arms to multi‐arm multi‐stage platform trials in progress
di: Thomas Burnett, et al.
Pubblicazione: (2024)

Skewness‐Corrected Confidence Intervals for Predictive Values in Enrichment Studies
di: Dadong Zhang, et al.
Pubblicazione: (2024)

Fiducial Confidence Intervals for Agreement Measures Among Raters Under a Generalized Linear Mixed Effects Model
di: Soumya Sahu, et al.
Pubblicazione: (2026)

Likelihood Confidence Intervals for Misspecified Cox Models
di: Yongwu Shao, et al.
Pubblicazione: (2026)

Confidence Intervals for AUC and pAUC by Empirical Likelihood
di: Yumin Zhao, et al.
Pubblicazione: (2025)

A multi‐arm multi‐stage platform design that allows preplanned addition of arms while still controlling the family‐wise error
di: Peter Greenstreet, et al.
Pubblicazione: (2024)

Group sequential designs for clinical trials when the maximum sample size is uncertain
di: Amin Yarahmadi, et al.
Pubblicazione: (2024)

Confidence Intervals and Sample Size for the ICC in Two‐Way ANOVA Models
di: Dipro Mondal, et al.
Pubblicazione: (2025)

Confidence Interval Construction for Causally Generalized Estimates With Target Sample Summary Information
di: Yi Chen, et al.
Pubblicazione: (2026)

RMST for Interval‐Censored Data in Oncology Clinical Trials
di: Xiyuan Gao, et al.
Pubblicazione: (2025)

A hybrid approach to sample size re‐estimation in cluster randomized trials with continuous outcomes
di: Samuel K Sarkodie, et al.
Pubblicazione: (2024)

Validation of predicted individual treatment effects in out of sample respondents
di: Alena Kuhlemeier, et al.
Pubblicazione: (2024)

Asymptotic Confidence Interval, Sample Size Formulas and Comparison Test for the Agreement Intra‐Class Correlation Coefficient in Inter‐Rater Reliability Studies
di: Abderrahmane Bourredjem, et al.
Pubblicazione: (2024)

Adaptive Biomarker‐Based Design for Early Phase Clinical Trials
di: Alessandra Serra, et al.
Pubblicazione: (2025)

Adaptive Designs in Trials With Time‐to‐Event Endpoints and Covariate Adjustment
di: Daniel Backenroth, et al.
Pubblicazione: (2026)

A Bayesian Treatment Selection Design for Phase II Randomised Cancer Clinical Trials
di: Moka Komaki, et al.
Pubblicazione: (2026)

An Augmented Approach for Regression Analysis of Case‐Cohort Interval‐Censored Failure Time Data
di: Yichen Lou, et al.
Pubblicazione: (2025)

Confidence intervals for odds ratio from multistage randomized phase II trials
di: Shiwei Cao, et al.
Pubblicazione: (2024)

A Generalized Phase I/II Dose Optimization Trial Design With Multi‐Categorical and Multi‐Graded Outcomes
di: Yichen Yan, et al.
Pubblicazione: (2025)

Active‐Controlled Trial Design for HIV Prevention Trials With a Counterfactual Placebo
di: Fei Gao, et al.
Pubblicazione: (2025)

A Practical Framework to Design Immunization Studies Based on the Beta Distribution
di: Stefan Embacher, et al.
Pubblicazione: (2025)

A Partially Randomized Patient Preference, Sequential, Multiple‐Assignment, Randomized Trial Design Analyzed via Weighted and Replicated Frequentist and Bayesian Methods
di: Marianthie Wank, et al.
Pubblicazione: (2024)

The Design of Large‐Scale Plasma Donation Trials
di: Kecheng Li, et al.
Pubblicazione: (2025)

Bayesian Response‐Adaptive Randomization for Cluster Randomized Controlled Trials
di: Yunyi Liu, et al.
Pubblicazione: (2026)

Response‐Adaptive Randomization Procedure in Clinical Trials with Surrogate Endpoints
di: Jingya Gao, et al.
Pubblicazione: (2024)

The Win Ratio Approach in Bayesian Monitoring for Two‐Arm Phase II Clinical Trial Designs With Multiple Time‐To‐Event Endpoints
di: Xinran Huang, et al.
Pubblicazione: (2024)

Safety‐Driven Response Adaptive Randomization: An Application in Noninferiority Oncology Trials
di: Maria Vittoria Chiaruttini, et al.
Pubblicazione: (2026)

Bayesian Ordered Lattice Design for Phase I Clinical Trials
di: Gi‐Ming Wang, et al.
Pubblicazione: (2026)

Design and Analysis of N‐Of‐1 Trials That Incorporate Sequential Monitoring
di: Shu Jiang, et al.
Pubblicazione: (2025)

Preference‐Informed Cluster Randomized Design for Pragmatic Clinical Trials
di: Yuwei Cheng, et al.
Pubblicazione: (2026)

Sample Size Calculation in Dose Optimization Trials Using the Margin of Practical Non‐Inferiority
di: Hakim‐Moulay Dehbi, et al.
Pubblicazione: (2025)

Sequential Monitoring of Covariate‐Adaptive Randomized Clinical Trials With Non‐Parametric Approaches
di: Xiaotian Chen, et al.
Pubblicazione: (2025)

A Biomarker Signature‐Guided Clinical Trial Design for Precision Medicine
di: Yuan Li, et al.
Pubblicazione: (2025)

On Inclusion of Covariates in Model Based Dose Finding Clinical Trial Designs
di: Adrien Ollier, et al.
Pubblicazione: (2025)

A Biomarker‐Based Dose–Schedule Optimization Design for Immunotherapy Trials
di: Yingjie Qiu, et al.
Pubblicazione: (2026)

DOD ‐ SSR : An Adaptive Seamless Phase II / III Design With Dose Optimization Decision and Sample Size Re‐estimation
di: Meizi Liu, et al.
Pubblicazione: (2025)

The Cox Model With Adaptive Fused Group Bridge Penalty to Incorporate Historical Data Into the Analysis of Clinical Trials With an Application to BMT CTN 1101
di: Xi Fang, et al.
Pubblicazione: (2025)